Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD36, also known as the oxidized LDL receptor, is a multifunctional membrane glycoprotein and a member of the class B scavenger receptor family. It is widely expressed on various cell types and plays critical roles in lipid metabolism, immunity, angiogenesis regulation, and disease pathogenesis. CD36 binds to a diverse array of ligands including oxidized low-density lipoprotein (oxLDL), long-chain fatty acids and proteins with thrombospondin structural homology repeat (TSR) domains. Its function in oxLDL uptake by macrophages contributes significantly to foam cell formation in atherosclerotic lesions. It also regulates angiogenesis, fatty acid transport, and immune responses.
Blocking CD36 mediated functions reduces foam cell formation and plaque progression in atherosclerosis; Inhibiting CD36 suppresses tumor growth and metastasis by targeting metabolic reprogramming and stemness features
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD36 Molecule (CD36).